Most coronavirus-positive cancer patients are asymptomatic
Most studies have shown that many cancer patients are at [...]
Pazopanib for poor risk kidney cancer patients
Pazopanib is used for first-line metastatic RCC treatment, but the [...]
Partial nephrectomy for patients with rare Xp11.2 translocation kidney cancer
XP11.2 translation renal cell carcinoma (RCC) is a very rare [...]
COVID-19 outcomes with anticancer treatments
There is a lot of ongoing research to understand the [...]
Impact of delay in surgery or time to surgery on kidney cancer outcomes
A recent study published in the Journal of Urology this [...]
The effect of age and gender on outcomes in kidney cancer
In this interview, Dr Rana McKay discusses the impact of [...]
Immune-related adverse events and clinical outcome in kidney cancer treated with nivolumab
In a paper published in Clinical Genitourinary Cancer the link [...]
Challenges of early detection of renal cell carcinoma
The incidence of kidney cancer in the UK has risen [...]
Integrative oncology: using evidence-based medicine to improve patient outcomes and quality of life
A recent article published in Cancer Therapy Advisor describes what [...]
Fat near kidney tumours plays a critical role in treatment response
It is already known that obesity increases the risk of [...]
